The use of oxygen in metabolism allows a high-energy output accompanied of the deleterious oxygen effects due to oxygen partial reduction (Halliwell and Gutteridge, 1997
Life Sciences, Indian Institute of Science (IISc) , Banglore, India The discovery of GLP-1 agonists reminds us that science not only treats diseases but it transforms lives. - Prasenjit Naskar Have you heard the recent news that surfaced regarding celebrities suddenly losing weight
Our membership offers a personalized plan to help jump start you to your weight goals
Yes, Trulicity (dulaglutide) can cause skin rash , though this is not among the most commonly reported side effects
Polycystic Ovary Syndrome (PCOS) - 5-10% of women 50% lower glutathione levels compared to women without PCOS 3-4x higher risk of preeclampsia 3x higher risk of gestational diabetes Critical concern: With 50% lower baseline glutathione, the "safe" dose is effectively cut in half IVF Conception - 2-5% of births (up to 6-8% in some countries) Women who conceive via IVF experience dramatic antioxidant depletion: 70% reduction in plasma antioxidant capacity 83% reduction in follicular fluid antioxidant capacity 50-100%+ increase in oxidative stress markers With over 5 million babies born via IVF globally, this represents a large high-risk population Gallbladder Dysfunction - 10% of pregnant women Up to 10% develop gallstones or biliary sludge Intrahepatic cholestasis: 0.4-10% of pregnancies CRITICAL: Fatal Outcomes Documented at Therapeutic Doses The first case of a pregnant woman with intrahepatic cholestasis who died from liver failure after taking THERAPEUTIC/NORMAL doses of acetaminophen was reported in 2022
Our team has found that patients on concurrent GLP-1 therapy (semaglutide, tirzepatide) often benefit from twice-weekly lipo c dosage during the first 812 weeks of treatment, when caloric deficit is steepest and hepatic fat mobilisation is most active
